JOURNAL OF CHEMICAL RESEARCH 2013 85
4-Imino-N′-(2-oxoindolin-3-ylidene)-3-phenyl-2-thioxothiazolidin-
5-carbohydrazide (10): To a solution of compound 2 (2.28 g, 0.01 mol)
in ethanol (15 mL) containing triethylamine (0.5 mL), elemental sulfur
(0.32 g, 0.01 mol) and phenyl isothiocyanate (1.35 mL, 0.01 mol)
were added. The reaction mixture was heated at 60 °C for 2 h with
continuous stirring. After cooling, the reaction mixture was acidified
with cold dilute acetic acid. The precipitated solid was filtered off,
washed several times with cold water and recrystallised from toluene
to give 10 as reddish brown crystals; m.p. 208–209 °C, yield 79%.
IR (ν/cm−1): 3413, 3238 (br.s) (NH), 1699 (C=O), 1624 (C=N), 1364
was insoluble in toluene was recrystallised from 1,4-dioxane to give
15.
14:Yellow crystals; m.p. 200–202 °C, yield 19%. IR (ν/cm−1): 3201
(NH), 2262 (C≡N), 1725, 1696, 1619 (C=O). MS m/z (%): 302 (M.+;
1
8.8), 259 (12.5), 230 (48.0), 160 (71.3), 132 (100), 104 (77.5). H
NMR (DMSO-d6) δ (ppm): 12.63 (s, 1H, enolic OH, exchangeable
with D2O), 11.33 (s, 1H, NH, exchangeable with D2O), 7.54 (d, 1H,
J = 7.5 Hz), 7.39 (dd, 1H, J = 6.3 Hz; J = 4.5 Hz), 7.11 (dd, 1H,
J = 7.8 Hz; J = 7.5 Hz), 6.94 (d, 1H, J = 8.4 Hz), 4.41 (s, 2H), 4.21 (s,
1H). Anal. Calcd for C13H10N4O3S (302.31): C, 51.65; H, 3.33; N,
18.53; S, 10.61. Found: C, 51.62; H, 3.32; N, 18.50; S, 10.64%.
15: Brown crystals; m.p. 272–274 °C, yield 58%. IR (ν/cm-1): 3438,
3176 (NH), 1699, 1660 (C=O), 1620 (C=N). MS m/z (%): 302 (M.+;
15.5), 161 (100), 142 (56.7), 132 (10.7), 114 (29.6), 104 (28.4), 86
1
(C=S). H NMR (CDCl3) δ (ppm): 11.2 (s, 1H, NH, exchangeable
with D2O), 9.9 (s, 1H, NH, exchangeable with D2O), 8.6–7.0 (m,
9Harom.), 3.7 (br.s, 2H, exchangeable with D2O). MS m/z (%): 395 (M.+;
35.4), 235 (76.3), 207 (15.7), 161 (70.7), 135 (36.9), 104 (51.1), 77
(100). Anal. Calcd for C18H13N5O2S2 (395.46): C, 54.67; H, 3.31; N,
17.71; S, 16.22. Found: C, 54.47; H, 3.29; N, 17.96; S, 16.25%.
7-(3,4-Dimethoxyphenyl)-2′,5-dioxo-3,5-dihydro-1H-spiro{[1,2,4]
triazolo[1,5-a]pyridine-2,3′-indoline}-6,8-dicarbonitrile (11): A mix-
ture of 2 (1.0 g, 4.4 mmol) and 2-(3,4-dimethoxybenzylidene)malo-
nonitrile (0.94 g, 4.4 mol) in 1,4-dioxane (25 mL) in the presence of
triethylamine (0.5 mL) was heated under reflux for 3 h. the reaction
mixture was concentrated and acidified with cold dilute acetic acid.
The solid which separated out was filtered off, washed several times
with cold water and recrystallised from ethanol to give 11 as brown
crystals; m.p. 188–190 °C, yield 71%. IR (ν/cm−1): 3428 (NH), 2209
1
(28.4). H NMR (DMSO-d6) δ (ppm): 12.44 (br.s, 1H, enolic OH,
exchangeable with D2O), 11.76 (s, 1H, NH, exchangeable with D2O),
11.20 (s, 1H, NH, exchangeable with D2O), 7.46 (d, 1H, J = 7.2 Hz),
7.34 (d, 1H, J = 7.8 Hz), 7.09 (d, 1H, J = 7.8 Hz), 6.93 (d, 1H, J =
7.8 Hz), 3.80 (s, 2H), 3.29 (s, 1H). Anal. Calcd for C13H10N4O3S
(302.31): C, 51.65; H, 3.33; N, 18.53; S, 10.61. Found: C, 51.62; H,
3.31; N, 18.55; S, 10.64%.
Received 16 September 2012; accepted 3 December 2012
Paper 1201426 doi: 10.3184/174751912X13567100793191
Published online: 13 February 2013
1
(C≡N), 1699 (C=O). H NMR (CDCl3) δ (ppm): 11.4 (s, 1H, NH,
exchangeable with D2O), 9.9 (s, 1H, NH, exchangeable with D2O), 8.7
(s, 1H, NH, exchangeable with D2O), 8.2–6.9 (m, 7Harom.), 3.89 (s, 6H,
2OMe). MS m/z (%): 412 (M–CO, 26.1), 252 (17.4), 216 (39.1), 119
(56.5), 92 (52.2), 51 (100). Anal. Calcd for C23H16N6O4 (440.41): C,
62.72; H, 3.66; N, 19.08. Found: C, 62.37; H, 3.46; N, 19.11%.
1-(3-Oxo-2,3-dihydrocinnolin-4(1H)-ylidene)carbonohydrazide
(12): A mixture of 2 (1.0 g, 4.4 mmol) and hydrazine hydrate 80%
(0.01 mol) in 1,4-dioxane (20 mL) was heated under reflux for 2 h. the
solid formed after cooling was collected by filtration and recrystal-
lised from ethanol to give 12 as pale green crystals; m.p. 244–246 °C,
yield 72%. IR (ν/cm−1): 3358 (s), 3154 (br.) (NH), 1686, 1656 (C=O).
MS m/z (%): 234 (M.+; 33.3), 132 (20.5), 105 (43.6), 91 (56.4), 51
(100). Anal. Calcd for C9H10N6O2 (234.21): C, 46.15; H, 4.30; N,
35.88. Found: C, 46.38; H, 4.18; N, 35.68.
Ethyl 5′-amino-2,7′-dioxo-4′,7′-dihydro-1′H-spiro[indoline-3,2′-
pyrazolo[1,5-a]pyrimidine]-3′-carboxylate (13): To a solution of
compound 2 (1.0 g, 4.4 mmol) in ethanol (20 mL) containing piperi-
dine (0.5 mL), ethyl cyanoacetate (0.49 g, 4.4 mmol) was added. The
reaction mixture was heated under reflux for 3 h, then poured on ice
and acidified with dilute acetic acid. The precipitated solid was
filtered off, washed several times with cold water and recrystallised
from ethanol to give 13 as brown crystals; m.p. 212–214 °C, yield
32%. IR (ν/cm−1): 3358, 3260, 3157 (NH2, NH), 1685 (C=Oester, che-
lated H-bonding), 1658 (C=O). MS m/z (%): 341 (M.+; 46.7). 1H NMR
(DMSO-d6) δ (ppm): 10.65 (s, 1H, NH, exchangeable with D2O),
10.5 (s, 1H, NH, exchangeable with D2O), 9.50–9.40 (d, 2H, NH2,
exchangeable with D2O), 8.70 (s, 1H, NH, exchangeable with
D2O),7.36–6.84 (m, 4Harom.), 4.27–4.20 (q, 2H, J = 6.5 Hz), 2.51 (s,
1H), 1.03 (t, 3H, J = 6.5 Hz). Anal. Calcd for C16H15N5O4 (341.32): C,
56.30; H, 4.43; N, 20.52. Found: C, 56.12; H, 4.40; N, 20.45%.
2-Cyano-N-(2,4′-dioxospiro[indoline-3,2′-thiazolidine]-3′-
yl)acetamide (14) and 2-(4-oxo-4,5-dihydrothiazol-2-yl)-N′-(2-oxoin-
dolin-3-ylidene)acetohydrazide (15): A mixture of compound 2
(1.0 g, 4.4 mmol) and thioglycolic acid (0.3 mL, 4.4 mmol) in dry
pyridine (20 mL) was heated under reflux for 3 h. after cooling the
reaction mixture was poured on ice cold acetic acid. The separated
solid was filtered off, washed several times with cold water and recrys-
tallised from toluene to give 14. The remaining solid product which
References
1
2
3
4
5
L. Zhou, Y. Liu, W. Zhang, P. Wei, C. Huang, J. Pei, Y. Yuan and L. Lai,
J. Med. Chem., 2006, 49, 3440.
M.E. Matheus, F.A. Violante, S.J. Garden, A.C. Pinto and P.D. Fernandes,
Eur. J. Pharmacol., 2007, 556, 200.
P.Yogeeswari, D. Sriram, R. Thirumurugan, J.V. Raghavendran, K. Sudhan,
R.K. Pavana and J. Stables, J. Med. Chem., 2005, 48, 6202.
K.L. Ine, J.M. Locke, M. Ranson, S.G. Pyne, and J.B. Bremner, J. Med.
Chem., 2007, 50, 5109.
J.M. Da Silva, S.J. Garden and A.C. Pinto, J. Braz. Chem. Soc., 2001, 12,
273.
6
7
V. Glover, J.M. Halket and P.J. Watkins, J. Neurochem., 1988, 51, 656.
S.K. Bhattacharya, V. Glover and I. McIntyre, Neurosci. Lett., 1982, 92,
218.
8
9
Z.H. Chohan, H. Pervez, and A. Rauf, J. Enz. Inhib. Med. Chem., 2004, 19,
417.
S.N. Pandeya, S. Smitha, M. Jyoti and S.K. Sridhar, Acta Pharm., 2005, 55,
27.
10 S. Bondock, A.E.G. Tarhoni and A.A. Fadda, Arkivoc, 2006, ix, 113.
11 A.P.M. Marcos, N.M. Dayse, P.F. Clarissa, L.N.Z. Kelvis and G.B. Helio,
J. Braz. Chem. Soc., 2008, 19, 1361.
12 M.R. Mahmoud, A.K. E1-Ziaty, M.F. Ismail and S.A. Shiba, Eur. J. Chem.,
2011, 2, 347.
13 M.R. Mahmoud, M.M. El-Shahawi and F.S.M. Abu El-Azm, Eur. J. Chem.,
2011, 2, 404.
14 M.R. Mahmoud, H.M.F. Madkour, E.A.A. El-Bordany and S.A. Soliman,
Eur. J. Chem., 2011, 2, 475.
15 M.R. Mahmoud, M.M. El-Shahawi, F.S.M. Abu El-Azm and S.E. Farahat,
Am. J. Org. Chem., 2011, 1, 14.
16 M.R. Mahmoud, W.S.I. Abou-Elmagd, H.A. Derbala and M.H. Hekal,
Chinese J. Chem., 2011, 29, 1446.
17 M.R. Mahmoud, W.S.I. Abou-Elmagd, S.S. Abd El-Wahab and
S.A. Soliman, J. Chem. Res., 2012, 66.
18 M.R. Mahmoud, W.S.I. Abou-Elmagd, H.A. Derbala and M.H. Hekal,
J. Chem. Res., 2012, 75.
19 M.R. Mahmoud, H.M.F. Madkour, M.M. Habashy and A.M. El-Shwaf,
Am. J. Org. Chem., 2012, 2, 39.
20 M.R. Mahmoud, A.K. E1-Ziaty and A.M. Hussein, World Appl. Sci. J.,
2012, 17, 101.
21 Y.S. Mohammed, H.A.A. Regaila, A.K.M. Gohar, F.F. Abdel-Latif and
E. Kh. Ahmed, Egypt. J. Pharm. Sci., 1988, 29, 419. [Chem. Abstr., 1989,
110, 231374].